Difference between revisions of "QIBA Overview"
Jump to navigation
Jump to search
Line 14: | Line 14: | ||
==See Also== | ==See Also== | ||
*[[Media:QIBA_Fact_Sheet_9-Oct-2015.pdf|QIBA Overview Fact Sheet]] ''October 2015'' | *[[Media:QIBA_Fact_Sheet_9-Oct-2015.pdf|QIBA Overview Fact Sheet]] ''October 2015'' | ||
− | *[[Media:QIBA task force report 11-3-11.pdf|QIBA Task Force Report]] ''August 2011'' | + | *[http://www.rsna.org/qiba RSNA QIBA page] |
− | + | **[[Media:QIBA task force report 11-3-11.pdf|QIBA Task Force Report]] ''August 2011'' | |
− | + | *[[Projects]] - | |
===Related Activities=== | ===Related Activities=== |
Revision as of 22:19, 4 May 2016
QIBA is an initiative to advance quantitative imaging and the use of imaging biomarkers in clinical trials and clinical practice by engaging researchers, healthcare professionals and industry . This involves:
- collaborating to identify needs, barriers, and solutions to develop and test consistent, reliable, valid, and achievable quantitative imaging results across imaging platforms, clinical sites, and time.
- accelerating the development and adoption of hardware and software standards needed to achieve accurate and reproducible quantitative results from imaging methods.
QIBA develops Profile specifications and coordinates the necessary research and qualification groundwork.
For more detail, refer to the Education page.
See Also
- QIBA Overview Fact Sheet October 2015
- RSNA QIBA page
- QIBA Task Force Report August 2011
- Projects -
Related Activities
- UPICT
- EIBALL
- QIBA Japan
- Pharma Imaging Network for Therapeutics and Diagnostics (PINTAD)